(Q86064057)
Statements
A phase I study of UGT1A1 *28/*6 genotype-directed dosing of irinotecan (CPT-11) in Korean patients with metastatic colorectal cancer receiving FOLFIRI (English)
Kyu-Pyo Kim
Yong Sang Hong
Jae-Lyun Lee
Ho-Sook Kim
Jae-Gook Shin
Jung Shin Lee